Hepatitis E virus incidence in patients with non-identified acute viral hepatitis in Mexico

Berebichez-Fridman, Roberto; Vázquez-Campuzano, Roberto; Galnares-Olalde, Javier Andrés; Blachman‐Braun, Ruben

doi:10.1016/j.hgmx.2016.04.001

Cited by 1 publication

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another evaluation of anti-HEV prevalence was conducted in 2016 with 624 samples from individuals from all the states in Mexico. The reported anti-HEV prevalence was 1.76%, and the main contributions were derived from the states of Baja California, Colima, and Campeche, located in the north, west, and south, respectively [ 54 ].…”

Section: Hev Seroprevalence In Mexicomentioning

confidence: 99%

Tracing the History of Hepatitis E Virus Infection in Mexico: From the Enigmatic Genotype 2 to the Current Disease Situation

Viera-Segura,

Calderón-Flores,

Batún-Alfaro

et al. 2023

Viruses

View full text Add to dashboard Cite

Hepatitis E virus (HEV) is the major cause of acute viral hepatitis worldwide. This virus is responsible for waterborne outbreaks in low-income countries and zoonosis transmission in industrialized regions. Initially, considered self-limiting, HEV may also lead to chronic disease, and evidence supports that infection can be considered a systemic disease. In the late 1980s, Mexico became a hot spot in the study of HEV due to one of the first virus outbreaks in Latin America related to enterically transmitted viral non-A, non-B hepatitis. Viral stool particles recovered from Mexican viral hepatitis outbreaks represented the first identification of HEV genotype (Gt) 2 (Gt2) in the world. No new findings of HEV-Gt2 have been reported in the country, whereas this genotype has been found in countries on the African continent. Recent investigations in Mexico have identified other strains (HEV-Gt1 and -Gt3) and a high frequency of anti-HEV antibodies in animal and human populations. Herein, the potential reasons for the disappearance of HEV-Gt2 in Mexico and the advances in the study of HEV in the country are discussed along with challenges in studying this neglected pathogen. These pieces of information are expected to contribute to disease control in the entire Latin American region.

show abstract

Section: Hev Seroprevalence In Mexicomentioning

confidence: 99%